Changing of the guard at Cardinal Health: Michael Kaufmann ascends to CFO
Jon Giacomin replaces Kaufmann as CEO of Cardinal Pharmaceutical segment
Following the previously announced retirement Jeffrey Henderson, Michael Kaufmann (photo), a 24-year veteran of the $91-billion/yr company, takes over as CFO. Kaufmann has been head of the Pharmaceutical segment (drug wholesaling, the predominant portion of Cardinal’s business) since 2009. Kaufmann’s “unique blend of financial acumen and extensive operational experience make him ideally suited to take the position of CFO," said George Barrett, chairman and CEO, in a statement. “I'm thrilled that this move also allows us to bring Jon Giacomin into the Pharmaceutical segment leadership role.”
Giacomin, previously president of US Pharmaceutical Distribution, has been with the company for 12 years and has held roles in packaging and supply chain services at the company.
Kaufmann is a member of the executive committee of the boards of the Healthcare Distribution Management Association and the National Association of Chain Drug Stores, and a trustee at Ohio Northern University. Kaufmann is the executive sponsor of the Cardinal Health Women's Initiative Network Employee Resource Group, which is dedicated to fostering partnerships that create a great place for women to work and grow their careers, while building a sustainable competitive advantage for Cardinal Health.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
